1The new development of the Right to Try Act on the expanded access of investigational new drugs in the USAGE Zhang-zhi97-1042The key factors affecting the quality of Chinese medicinal materials on the construction of Chinese Medicinal Material Information Traceability SystemLI Can, LIN Dan, YANG Chang-ming, HAN Wei105-1093Considerations on in vitro phosphate binding experiments for lanthanum carbonate chewable tabletsZANG Dan, MA Jing-yi, LI Min, LIU Shu-jie, GAO Li-li, ZHAI Ying-qi, YANG Jin-bo110-1134Synthesis of phosphodiesterase 9A inhibitor LW33QIAN Ri-bin, WANG Jian-song, YE Hai-hong, BAO Ying-xia114-1185Progress in study on hollow microneedles for transdermal drug deliveryTIAN Xia, WANG Ning, DING Jiang-sheng119-1246Research progress of MRI visualized microspheres for embolizationCUI Hao-ying, LIU Xiao-xin, FAN Tian-yuan125-1317Research progress in redox sensitive targeting nano drug delivery systemsZHOU Yi-lin, LIU Shu-lan, XIA Xin-hua, ZOU Man-shu, ZHOU Li-li132-1388Research advances in peptide drugs in treatment of neonatal hypoxic ischemic brain injuryHOU Xue-wen, QIU Jie139-1449Long-term efficacy,safety and tolerability of rilpivirine-based ART regimen in HIV-1 infected Chinese patientsZHANG Hong-wei, CAI Wei-ping, HE Hao-lan, LU Hong-zhou, ZHANG Ren-fang, LI Xing-wang, WU Yan, HUANG Xiao-jie, WU Hao145-14910Data analysis and enlightenment of pediatric drug clinical trialsSU Na, TIAN Li-juan150-15311The latest progress in research on clinical therapeutic agents of COVID-19GU Jue-fen154-16112Optimization of the refining technology of maggots oil and its effect on skin aging induced by D-galactose in miceJIANG Xiao-lin, CHEN Liang-yuan, NIU Jun, LUO Lu-xiang, YANG Quan, CHENG Xuan-xuan162-16913Preparation and evaluation of betastatin ethosomesWANG Hao, LIU Run-ze, DONG Jun-feng, ZHOU Jian-wen, HUANG Chun-yan, CHU Yu-meng, HAN Cui-yan170-17714Standardization of the first batch of national reference standard of brimonidine tartrateZHANG Yuan, GENG Ying, ZHU Rong-die, WU Yan-lin, GAO Hua178-18115Determination of two phenylhydrazine-like genotoxic impurities in celecoxib by LC-MSFENG Rui, CHEN Guan-jun, LIU Li, WANG Sheng182-18616Utilization analysis of antifungal drugs for deep tissue infections in our hospital during 2017 to 2019LAI Yan-jin, CHEN Su-zhen, WANG Jin-ye, SA Ke-jia187-192 